S100 antigenicity is used to identify poorly differentiated metastatic melanoma, and this protein family has been implicated in cell proliferation, metastasis, angiogenesis, invasion, and inflammation [36,51,52,53,54,55,56]. This evidence concerns the gene S100A1 and metastatic melanoma.